Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the british society of gene and cell therapy annual meeting 2015.
Authors
Gilham, David EAnderson, J
Bridgeman, J
Hawkins, Robert E
Exley, M
Stauss, H
Maher, J
Pule, M
Sewell, A
Bendle, G
Lee, S
Qasim, W
Thrasher, A
Morris, E
Affiliation
University of Manchester, Clinical and Experimental Immunotherapy Group, Institute of Cancer Sciences, Manchester, United KingdomIssue Date
2015-05
Metadata
Show full item recordAbstract
Adoptive T-cell therapy is delivering objective clinical responses across a number of cancer indications in the early phase clinical setting. Much of this clinical activity is taking place at major clinical academic centers across the United States. This review focuses upon cancer-focused cell therapy activity within the United Kingdom as a contribution to the 2015 British Society of Gene and Cell Therapy annual general meeting. This overview reflects the diversity and expansion of clinical and preclinical studies within the United Kingdom while considering the background context of this work against new infrastructural developments and the requirements of nationalized healthcare delivery within the UK National Health Service.Citation
Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the british society of gene and cell therapy annual meeting 2015. 2015, 26 (5):276-85 Hum Gene TherJournal
Human Gene TherapyDOI
10.1089/hum.2015.024PubMed ID
25860661Type
ArticleLanguage
enISSN
1557-7422ae974a485f413a2113503eed53cd6c53
10.1089/hum.2015.024
Scopus Count
Collections
Related articles
- T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
- Authors: Houot R, Schultz LM, Marabelle A, Kohrt H
- Issue date: 2015 Oct
- Adoptive T cell therapy for cancer in the clinic.
- Authors: June CH
- Issue date: 2007 Jun
- Chimeric antigen receptor T cell therapy: 25years in the making.
- Authors: Gill S, Maus MV, Porter DL
- Issue date: 2016 May
- Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.
- Authors: Kalos M, June CH
- Issue date: 2013 Jul 25
- Engineering Natural Killer Cells for Cancer Immunotherapy.
- Authors: Rezvani K, Rouce R, Liu E, Shpall E
- Issue date: 2017 Aug 2